Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Recruiting
Early Phase 1
Interventional Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 100
- Sex
- Male
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Principal Investigator's (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically significant tumors in patients who will undergo brachytherapy, as well as areas which are uninvolved or contain only clinically insignificant disease.
In the PI's clinical trial, the uninvolved regions (as defined by combined PET-MR-biopsy data) will …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adenocarcinoma of the prostate
* Performance Status \< 2
* Clinical stages (not radiographic stage) T1c - T2a, Nx or N0, Mx or M0
* Gleason 6-7 cancer
* Prostate volume \< 60 cc (if MRI and TRUS have conflicting values, then MRI value will be utilized)
* International Prostate…
Contacts